vs
Eventbrite, Inc.（EB）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Eventbrite, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.1倍（$73.5M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -11.1%，领先395.1%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -3.9%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -7.7%）
Eventbrite是源自美国的线下活动服务平台，为用户提供活动浏览、创建与推广服务，支持主办方免费在平台发布不限规模、不限数量的各类活动，是全球范围内活跃度较高的活动交易与推广平台。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
EB vs RIGL — 直观对比
营收规模更大
EB
是对方的1.1倍
$69.8M
营收增速更快
RIGL
高出25.1%
-3.9%
净利率更高
RIGL
高出395.1%
-11.1%
两年增速更快
RIGL
近两年复合增速
-7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $73.5M | $69.8M |
| 净利润 | $-8.2M | $268.1M |
| 毛利率 | 68.1% | 91.5% |
| 营业利润率 | -12.4% | 33.2% |
| 净利率 | -11.1% | 384.0% |
| 营收同比 | -3.9% | 21.2% |
| 净利润同比 | 2.5% | 1769.2% |
| 每股收益（稀释后） | $-0.08 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EBRIGL
| Q4 25 | $73.5M | $69.8M | ||
| Q3 25 | $71.7M | $69.5M | ||
| Q2 25 | $72.8M | $101.7M | ||
| Q1 25 | $73.8M | $53.3M | ||
| Q4 24 | $76.5M | $57.6M | ||
| Q3 24 | $77.8M | $55.3M | ||
| Q2 24 | $84.6M | $36.8M | ||
| Q1 24 | $86.3M | $29.5M |
净利润EBRIGL
| Q4 25 | $-8.2M | $268.1M | ||
| Q3 25 | $6.4M | $27.9M | ||
| Q2 25 | $-2.1M | $59.6M | ||
| Q1 25 | $-6.6M | $11.4M | ||
| Q4 24 | $-8.4M | $14.3M | ||
| Q3 24 | $-3.8M | $12.4M | ||
| Q2 24 | $1.1M | $-1.0M | ||
| Q1 24 | $-4.5M | $-8.2M |
毛利率EBRIGL
| Q4 25 | 68.1% | 91.5% | ||
| Q3 25 | 67.9% | 93.2% | ||
| Q2 25 | 67.5% | 95.6% | ||
| Q1 25 | 66.9% | 91.7% | ||
| Q4 24 | 68.2% | 89.9% | ||
| Q3 24 | 68.5% | 85.5% | ||
| Q2 24 | 70.9% | 92.4% | ||
| Q1 24 | 71.0% | 93.1% |
营业利润率EBRIGL
| Q4 25 | -12.4% | 33.2% | ||
| Q3 25 | -1.3% | 40.9% | ||
| Q2 25 | -8.7% | 60.1% | ||
| Q1 25 | -13.2% | 23.9% | ||
| Q4 24 | -10.2% | 28.9% | ||
| Q3 24 | -11.5% | 25.4% | ||
| Q2 24 | -7.6% | 1.2% | ||
| Q1 24 | -8.8% | -23.6% |
净利率EBRIGL
| Q4 25 | -11.1% | 384.0% | ||
| Q3 25 | 8.9% | 40.2% | ||
| Q2 25 | -2.9% | 58.6% | ||
| Q1 25 | -9.0% | 21.5% | ||
| Q4 24 | -11.0% | 24.9% | ||
| Q3 24 | -4.8% | 22.5% | ||
| Q2 24 | 1.3% | -2.8% | ||
| Q1 24 | -5.2% | -27.9% |
每股收益（稀释后）EBRIGL
| Q4 25 | $-0.08 | $14.11 | ||
| Q3 25 | $0.06 | $1.46 | ||
| Q2 25 | $-0.02 | $3.28 | ||
| Q1 25 | $-0.07 | $0.63 | ||
| Q4 24 | $-0.09 | $0.82 | ||
| Q3 24 | $-0.04 | $0.70 | ||
| Q2 24 | $0.01 | $-0.06 | ||
| Q1 24 | $-0.05 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $299.9M | $155.0M |
| 总债务越低越好 | $144.4M | $52.5M |
| 股东权益账面价值 | $179.1M | $391.5M |
| 总资产 | $647.2M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.81× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资EBRIGL
| Q4 25 | $299.9M | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | $441.5M | $77.3M | ||
| Q3 24 | $24.7M | $61.1M | ||
| Q2 24 | $56.7M | $49.1M | ||
| Q1 24 | $113.7M | $49.5M |
总债务EBRIGL
| Q4 25 | $144.4M | $52.5M | ||
| Q3 25 | $174.9M | $60.0M | ||
| Q2 25 | $241.3M | $60.0M | ||
| Q1 25 | $241.0M | $60.0M | ||
| Q4 24 | $240.7M | $60.0M | ||
| Q3 24 | $240.4M | $60.0M | ||
| Q2 24 | $358.7M | $60.0M | ||
| Q1 24 | $358.2M | $60.0M |
股东权益EBRIGL
| Q4 25 | $179.1M | $391.5M | ||
| Q3 25 | $189.1M | $117.6M | ||
| Q2 25 | $177.2M | $81.9M | ||
| Q1 25 | $173.3M | $18.6M | ||
| Q4 24 | $170.2M | $3.3M | ||
| Q3 24 | $179.8M | $-14.6M | ||
| Q2 24 | $176.2M | $-29.9M | ||
| Q1 24 | $184.1M | $-31.7M |
总资产EBRIGL
| Q4 25 | $647.2M | $513.6M | ||
| Q3 25 | $744.6M | $242.5M | ||
| Q2 25 | $784.1M | $206.7M | ||
| Q1 25 | $812.3M | $176.0M | ||
| Q4 24 | $752.3M | $164.0M | ||
| Q3 24 | $817.4M | $139.4M | ||
| Q2 24 | $894.5M | $128.4M | ||
| Q1 24 | $952.2M | $126.5M |
负债/权益比EBRIGL
| Q4 25 | 0.81× | 0.13× | ||
| Q3 25 | 0.92× | 0.51× | ||
| Q2 25 | 1.36× | 0.73× | ||
| Q1 25 | 1.39× | 3.23× | ||
| Q4 24 | 1.41× | 18.25× | ||
| Q3 24 | 1.34× | — | ||
| Q2 24 | 2.04× | — | ||
| Q1 24 | 1.95× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-60.8M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-60.9M | — |
| 自由现金流率自由现金流/营收 | -82.8% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $17.6M | — |
8季度趋势，按日历期对齐
经营现金流EBRIGL
| Q4 25 | $-60.8M | $22.0M | ||
| Q3 25 | $36.7M | $24.0M | ||
| Q2 25 | $-17.5M | $30.5M | ||
| Q1 25 | $59.4M | $-893.0K | ||
| Q4 24 | $-45.3M | $14.5M | ||
| Q3 24 | $44.6M | $21.7M | ||
| Q2 24 | $-32.3M | $302.0K | ||
| Q1 24 | $68.6M | $-5.0M |
自由现金流EBRIGL
| Q4 25 | $-60.9M | — | ||
| Q3 25 | $36.6M | — | ||
| Q2 25 | $-17.5M | — | ||
| Q1 25 | $59.4M | — | ||
| Q4 24 | $-45.3M | — | ||
| Q3 24 | $44.4M | — | ||
| Q2 24 | $-32.4M | — | ||
| Q1 24 | $68.2M | — |
自由现金流率EBRIGL
| Q4 25 | -82.8% | — | ||
| Q3 25 | 51.1% | — | ||
| Q2 25 | -24.1% | — | ||
| Q1 25 | 80.4% | — | ||
| Q4 24 | -59.2% | — | ||
| Q3 24 | 57.1% | — | ||
| Q2 24 | -38.3% | — | ||
| Q1 24 | 79.1% | — |
资本支出强度EBRIGL
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.4% | — |
现金转化率EBRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 5.76× | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | -30.37× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EB
| US | $52.0M | 71% |
| Other | $21.6M | 29% |
RIGL
暂无分部数据
